Tabes Dorsalis risk factors
Tabes Dorsalis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Tabes Dorsalis risk factors On the Web |
American Roentgen Ray Society Images of Tabes Dorsalis risk factors |
Risk calculators and risk factors for Tabes Dorsalis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
There are no established risk factors for [disease name].
OR
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
Risk Factors
- There are no established risk factors for [disease name].
OR
- The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
- Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
Common Risk Factors
- Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
- Common risk factors in the development of [disease name] include:[1][2]
- HIV infection
- Male patients
- High serum RPR titer
Less Common Risk Factors
- Less common risk factors in the development of [disease name] include:
- [Risk factor 1]
- [Risk factor 2]
- [Risk factor 3]
References
- ↑ Vidal-Bermúdez JE, Bonasser-Filho F, Schiavon-Nogueira R (2004). "[Syphilitic meningomyelitis in a patient with AIDS]". Rev Neurol. 38 (10): 998–9. PMID 15175987.
- ↑ Shi M, Peng RR, Gao Z, Zhang S, Lu H, Guan Z; et al. (2016). "Risk profiles of neurosyphilis in HIV-negative patients with primary, secondary and latent syphilis: implications for clinical intervention". J Eur Acad Dermatol Venereol. 30 (4): 659–66. doi:10.1111/jdv.13514. PMID 26660338.